Abstract
Objective: it aimed to analyze the relationship between somatization in elderly patients with major depressive disorder (MDD) and brain-derived neurotrophic factor (BDNF), IL-6, IL-10, and TNF-α cognitive function, and sleep quality(SQ).
Method: 80 elderly patients with MDD were grouped based on the somatic self-rating scale (SSS): the subjects with somatic symptoms (SS) as the AG and the subjects without SS as the BG. Additionally, 25 healthy volunteers from the same period were included as the control group (CG). SQ scores, BDNF and its precursor (ProBDNF), and cognitive function scores of the subjects were collected.
Result: the SQ and SS scores of AG and BG were visibly higher as against CG, and those of AG were visibly higher in contrast to BG; The cognitive function scores of AG and BG were visibly lower as against CG, and the score of AG was visibly lower in contrast to BG (P <0.05). There was similar in BDNF and ProBDNF levels between AG and BG (P >0.05). CRP, IL-6, IL-10, and TNF-α in both AG and BG were visibly higher as against CG; Those were visibly higher in AG as against BG (P <0.05).The SS scores of the patients suggested a visible negative correlation with cognitive function scores and a highly visible positive correlation with SQ scores.
Conclusion: somatization symptoms may affect the SQ and cognitive function of people with depression, leading to an exacerbation of inflammatory responses; BDNF and ProBDNF levels may be more influenced by the overall state of depression rather than being determined solely by SS.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.